Literature DB >> 5652477

Myocardial sarcoidosis.

F A Bashour, T McConnell, W Skinner, M Hanson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5652477     DOI： 10.1378/chest.53.4.413

Source DB:  PubMed          Journal:  Dis Chest        ISSN： 0096-0217


× No keyword cloud information.
  9 in total

1.  Classification of the secondary cardiomyopathies. The pathologist's view.

Authors:  A Pomerance
Journal:  Postgrad Med J       Date:  1972-12       Impact factor: 2.401

2.  Sarcoid heart disease.

Authors:  H A Fleming
Journal:  Br Heart J       Date:  1974-01

3.  Heart block resulting from myocardial sarcoidosis.

Authors:  F J Fawcett; M J Goldberg
Journal:  Br Heart J       Date:  1974-02

4.  Myocardial sarcoidosis.

Authors:  P Ghosh; H A Fleming; G A Gresham; P G Stovin
Journal:  Br Heart J       Date:  1972-08

5.  Systemic sarcoidosis with refractory ventricular tachycardia and heart failure.

Authors:  M J Walsh
Journal:  Br Heart J       Date:  1978-08

6.  Acute breathlessness, heart block and sudden death in a 66-year-old man.

Authors:  H H Kong; H Sheldon
Journal:  Can Med Assoc J       Date:  1982-10-15       Impact factor: 8.262

7.  Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia.

Authors:  Hideki Futamatsu; Jun-ichi Suzuki; Susumu Adachi; Hiroyuki Okada; Kenichiro Otomo; Takahiro Ohara; Yuji Hashimoto; Tsunekazu Kakuta; Yoshito Iesaka; Hiroaki Yamaguchi; Harumizu Sakurada; Akira Sato; Tohru Obayashi; Akihiro Niwa; Kenzo Hirao; Mitsuaki Isobe
Journal:  Int J Cardiovasc Imaging       Date:  2006-03-14       Impact factor: 2.357

Review 8.  Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations.

Authors:  M Sekiguchi; Y Yazaki; M Isobe; M Hiroe
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

9.  Sarcoidosis: histopathological definition and clinical diagnosis.

Authors:  D N Mitchell; J G Scadding; B E Heard; K F Hinson
Journal:  J Clin Pathol       Date:  1977-05       Impact factor: 3.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.